Related Experiment Video
Updated: Jun 25, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Aptamer-mediated therapeutic strategies provide a potential approach for cancer
Bingshuo Yan1, Yuting Li1, Shiming He1
1School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, People's Republic of China.
Abstract:
The treatment of tumors still faces considerable challenges. While conventional treatments such as surgery, chemotherapy, and radiation therapy provide some curative effects, their side effects and limitations highlight the importance of finding more precise treatment strategies. Aptamers have become an important target molecule in the field of drug delivery systems due to their good affinity and targeting, and they have gradually become an important link from basic research to clinical application. In this paper, we discussed the latest progress of aptamer-mediated nanodrugs, as well as aptamer-mediated photodynamic therapy, photothermal therapy, and immunotherapy strategies for tumor treatment, and explored the possibility of aptamer-mediated therapy for accurate tumor treatment. The purpose of this review is to provide novel insights for treating tumors with aptamer-mediated therapies by summarizing these innovative strategies, thereby ultimately enhancing the therapeutic efficacy for cancer patients.
Insights
Aptamers offer precise tumor targeting for advanced cancer therapies. This review explores aptamer-nanodrugs, photodynamic, photothermal, and immunotherapy strategies to improve treatment efficacy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Conventional tumor treatments like surgery, chemotherapy, and radiation have limitations and side effects.
- Aptamers, with their high affinity and targeting capabilities, are crucial for advanced drug delivery systems.
- Bridging basic research and clinical application, aptamers are key in developing novel cancer therapies.
Purpose of the Study:
- To review the latest advancements in aptamer-mediated nanodrugs for tumor treatment.
- To explore aptamer-based strategies in photodynamic therapy, photothermal therapy, and immunotherapy.
- To assess the potential of aptamer-mediated therapies for accurate and enhanced tumor treatment.
Main Methods:
- Literature review of recent progress in aptamer-mediated nanomedicine.
- Analysis of aptamer applications in various cancer therapeutic modalities.
- Exploration of aptamer-based targeting mechanisms in nanodrug delivery.
Main Results:
- Aptamer-nanodrugs demonstrate significant potential for targeted delivery.
- Aptamer-mediated photodynamic, photothermal, and immunotherapy show promising results in preclinical studies.
- Integration of aptamers enhances the precision and efficacy of diverse cancer treatment strategies.
Conclusions:
- Aptamer-mediated therapies represent a significant advancement in precision oncology.
- These strategies offer improved therapeutic outcomes with potentially reduced side effects.
- Further research into aptamer-based approaches could revolutionize cancer patient treatment.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Treatment Resistant Cancers
Gene Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...